These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 33626003)

  • 1. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory effect of Di'ao Xinxuekang on TLR4/MyD88/NF-κB signaling pathway in atherosclerotic rats].
    Zhang WZ; Li GY; Qi Q; Na S; Lyu L; Chen GL
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):602-608. PubMed ID: 32237519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taohong Siwu decoction ameliorates atherosclerosis in rats possibly through toll-like receptor 4/myeloid differentiation primary response protein 88/nuclear factor-κB signal pathway.
    Fengjin C; Peng Z; Guoying LI; Weizhi Z; Yanyan Z; Daiyin P; Guangliang C
    J Tradit Chin Med; 2024 Feb; 44(1):103-112. PubMed ID: 38213245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
    Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
    Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
    Zhao H; Tian H
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23566. PubMed ID: 37888945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.
    Gong XW; Xu YJ; Yang QH; Liang YJ; Zhang YP; Wang GL; Li YY
    Chin J Integr Med; 2019 Mar; 25(3):216-224. PubMed ID: 29335857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.
    Dang WT; Xu D; Zhou JG
    Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
    Shen S; Wang K; Zhi Y; Shen W; Huang L
    Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of soothing liver and invigorating spleen recipes on NF-kappaB signal pathway related genes and proteins in primary hepatocytes of rats with NASH].
    Yang QH; Xu YJ; Feng GF; Yang XS; Han L; Zhang YP; Wang H
    Zhong Yao Cai; 2013 Sep; 36(9):1469-76. PubMed ID: 24620695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
    Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
    Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
    Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways.
    Hu N; Guo C; Dai X; Wang C; Gong L; Yu L; Peng C; Li Y
    J Ethnopharmacol; 2020 Nov; 262():113275. PubMed ID: 32810620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of regulatory effects of TLR4 and NF-κB on primary biliary cholangitis.
    Yu Y; Li MP; Xu B; Fan F; Lu SF; Pan M; Wu HS
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3951-3959. PubMed ID: 31115023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism].
    Qi SY; Huang H; Li YK; Pei LG; Zhang WJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):611-615. PubMed ID: 34821093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intervention mechanism of ginsenoside Rb_1 on liver steatosis in db/db obese mice based on TLR4/MyD88/NF-κB signaling pathway].
    Li TT; Zhang CF; Guo XY
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3600-3607. PubMed ID: 39041132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of catgut embedding at back-
    Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
    Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis.
    Liu S; Wu J; Chen P; Mohammed SAD; Zhang J; Liu S
    Biomed Res Int; 2022; 2022():4949148. PubMed ID: 36017390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.